| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Ying Lu | |
| Athos Bousvaros | |||
| Denise Jacobson | |||
| P2860 | cites work | A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 |
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease | Q28235756 | ||
| A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 | ||
| The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination | Q33845366 | ||
| Etiopathogenesis of inflammatory bowel diseases | Q33866988 | ||
| Abnormalities of uterine cervix in women with inflammatory bowel disease | Q33869002 | ||
| Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers | Q35636798 | ||
| Guidelines for immunizations in patients with inflammatory bowel disease | Q35912322 | ||
| Methods to avoid infections in patients with inflammatory bowel disease | Q36171733 | ||
| Current therapy of inflammatory bowel disease in children | Q36622124 | ||
| Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. | Q36782370 | ||
| Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases | Q36789194 | ||
| Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis | Q37051958 | ||
| Immune response to influenza vaccine in children with inflammatory bowel disease | Q37247576 | ||
| Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. | Q40486515 | ||
| Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine | Q40688732 | ||
| Influenza immunization in systemic lupus eruthematosus. A double-blind trial | Q40906916 | ||
| Response to measles-mumps-rubella vaccine in children on dialysis | Q43672745 | ||
| Outcome of cytomegalovirus infections in patients with inflammatory bowel disease | Q43684194 | ||
| Specific antibody response after influenza immunization in systemic lupus erythematosus. | Q44237951 | ||
| Evaluation of the vaccination status in pediatric renal transplant recipients | Q44302262 | ||
| Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine | Q44784519 | ||
| Overwhelming Varicella Pneumonia in a Patient with Crohnʼs Disease Treated with 6-Mercaptopurine | Q45115127 | ||
| Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome | Q45116890 | ||
| Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection | Q45722744 | ||
| ARDS caused by herpes simplex virus pneumonia in a patient with Crohn's disease: a case report | Q45764105 | ||
| Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. | Q45956101 | ||
| A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients | Q46044713 | ||
| Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease | Q46656401 | ||
| Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. | Q46803679 | ||
| Immune response after influenza vaccination in children with cancer. | Q53666988 | ||
| Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity | Q57769585 | ||
| Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy | Q60211000 | ||
| Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses | Q67264043 | ||
| Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients | Q69868198 | ||
| Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure | Q70272024 | ||
| Impaired response to pneumococcal vaccine in systemic lupus erythematosus | Q71429759 | ||
| Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases | Q73930794 | ||
| Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease | Q74449895 | ||
| Antigen-specific antibody responses in lupus patients following immunization | Q77430925 | ||
| Efficacy and safety of immunization for pre- and post- liver transplant children | Q78294024 | ||
| Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients | Q79370395 | ||
| Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease | Q80089348 | ||
| Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis | Q80211460 | ||
| Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease | Q80420684 | ||
| Higher incidence of abnormal Pap smears in women with inflammatory bowel disease | Q81452560 | ||
| Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area | Q82872300 | ||
| Vaccination against hepatitis B in children and adolescent patients on dialysis | Q93518467 | ||
| P433 | issue | 9 | |
| P921 | main subject | inflammation | Q101991 |
| inflammatory bowel diseases | Q917447 | ||
| immunization | Q1415366 | ||
| P304 | page(s) | 1417-1423 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Immunizations in patients with inflammatory bowel disease | |
| P478 | volume | 15 |
| Q33974382 | An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease |
| Q38235053 | Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease |
| Q46205741 | Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis |
| Q37844535 | Optimizing immunization in pediatric special risk groups |
| Q51378548 | Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls. |
| Q45844100 | Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD. |
| Q37845327 | Practical application of anti-TNF therapy for luminal Crohn's disease |
| Q38567716 | Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease |
| Q38243693 | Vaccinating the inflammatory bowel disease patient |
| Q33888397 | Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge |
| Q34674847 | Vaccination coverage in immunosuppressed patients: results of a regional health services research study |
| Q92264650 | Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany |
| Q38082568 | Vaccination strategies in patients with IBD. |
Search more.